363 related articles for article (PubMed ID: 15716855)
1. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice.
Laufs U; Gertz K; Huang P; Nickenig G; Böhm M; Dirnagl U; Endres M
Stroke; 2000 Oct; 31(10):2442-9. PubMed ID: 11022078
[TBL] [Abstract][Full Text] [Related]
3. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
[TBL] [Abstract][Full Text] [Related]
4. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice.
Amin-Hanjani S; Stagliano NE; Yamada M; Huang PL; Liao JK; Moskowitz MA
Stroke; 2001 Apr; 32(4):980-6. PubMed ID: 11283400
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage.
Jung KH; Chu K; Jeong SW; Han SY; Lee ST; Kim JY; Kim M; Roh JK
Stroke; 2004 Jul; 35(7):1744-9. PubMed ID: 15166393
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal of statin treatment abrogates stroke protection in mice.
Gertz K; Laufs U; Lindauer U; Nickenig G; Böhm M; Dirnagl U; Endres M
Stroke; 2003 Feb; 34(2):551-7. PubMed ID: 12574574
[TBL] [Abstract][Full Text] [Related]
8. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
10. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.
Endres M; Laufs U; Huang Z; Nakamura T; Huang P; Moskowitz MA; Liao JK
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8880-5. PubMed ID: 9671773
[TBL] [Abstract][Full Text] [Related]
11. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
[TBL] [Abstract][Full Text] [Related]
12. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
[TBL] [Abstract][Full Text] [Related]
13. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats.
Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH
J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of LOX-1 by statins may relate to upregulation of eNOS.
Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F
Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125
[TBL] [Abstract][Full Text] [Related]
16. The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
Zhang L; Zhang ZG; Liu XS; Hozeska-Solgot A; Chopp M
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2470-5. PubMed ID: 17717296
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia.
Sata M; Nishimatsu H; Suzuki E; Sugiura S; Yoshizumi M; Ouchi Y; Hirata Y; Nagai R
FASEB J; 2001 Nov; 15(13):2530-2. PubMed ID: 11641268
[TBL] [Abstract][Full Text] [Related]
18. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits.
Lapchak PA; Han MK
Brain Res; 2009 Dec; 1303():144-50. PubMed ID: 19781532
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia.
Cimino M; Balduini W; Carloni S; Gelosa P; Guerrini U; Tremoli E; Sironi L
Neurotoxicology; 2005 Oct; 26(5):929-33. PubMed ID: 15923039
[TBL] [Abstract][Full Text] [Related]
20. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
